PortfoliosLab logoPortfoliosLab logo
KOD vs. AVXL
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

KOD vs. AVXL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Kodiak Sciences Inc. (KOD) and Anavex Life Sciences Corp. (AVXL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, KOD achieves a 32.51% return, which is significantly higher than AVXL's -27.53% return.


KOD

1D
1.15%
1M
2.26%
YTD
32.51%
6M
34.97%
1Y
920.66%
3Y*
72.33%
5Y*
-15.89%
10Y*

AVXL

1D
1.57%
1M
-4.27%
YTD
-27.53%
6M
-30.83%
1Y
-72.26%
3Y*
-31.87%
5Y*
-36.48%
10Y*
-5.52%
*Multi-year figures are annualized to reflect compound growth (CAGR)

KOD vs. AVXL - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
KOD
Kodiak Sciences Inc.
32.51%181.01%227.30%-57.54%-91.55%-42.29%104.18%913.38%-29.00%
AVXL
Anavex Life Sciences Corp.
-27.53%-66.85%15.36%0.54%-46.60%221.11%108.49%66.03%-41.57%

Correlation

The correlation between KOD and AVXL is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.26

Correlation (3Y)
Calculated over the trailing 3-year period

0.34

Correlation (5Y)
Calculated over the trailing 5-year period

0.42

Correlation (All Time)
Calculated using the full available price history since Oct 4, 2018

0.37

The correlation between KOD and AVXL shifts across timeframes, from 0.26 (1 year) to 0.42 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS

KOD:

-$4.11

AVXL:

-$0.46

Total Revenue (TTM)

KOD:

$0.00

AVXL:

$0.00

Gross Profit (TTM)

KOD:

-$26.49M

AVXL:

$0.00

EBITDA (TTM)

KOD:

-$190.85M

AVXL:

-$28.87M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

KOD vs. AVXL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KOD
KOD Risk / Return Rank: 9999
Overall Rank
KOD Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
KOD Sortino Ratio Rank: 9898
Sortino Ratio Rank
KOD Omega Ratio Rank: 9797
Omega Ratio Rank
KOD Calmar Ratio Rank: 100100
Calmar Ratio Rank
KOD Martin Ratio Rank: 9999
Martin Ratio Rank

AVXL
AVXL Risk / Return Rank: 99
Overall Rank
AVXL Sharpe Ratio Rank: 99
Sharpe Ratio Rank
AVXL Sortino Ratio Rank: 99
Sortino Ratio Rank
AVXL Omega Ratio Rank: 77
Omega Ratio Rank
AVXL Calmar Ratio Rank: 77
Calmar Ratio Rank
AVXL Martin Ratio Rank: 1414
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KOD vs. AVXL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Kodiak Sciences Inc. (KOD) and Anavex Life Sciences Corp. (AVXL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


KODAVXLDifference
Sharpe ratioReturn per unit of total volatility

+7.66

Sortino ratioReturn per unit of downside risk

+6.81

Omega ratioGain probability vs. loss probability

1.64

0.82

+0.82

Calmar ratioReturn relative to maximum drawdown

25.67

-0.89

+26.55

Martin ratioReturn relative to average drawdown

60.88

-1.23

+62.11

KOD vs. AVXL - Sharpe Ratio Comparison

The current KOD Sharpe Ratio is 6.84, which is higher than the AVXL Sharpe Ratio of -0.82. The chart below compares the historical Sharpe Ratios of KOD and AVXL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

KOD vs. AVXL - Drawdown Comparison

The maximum KOD drawdown since its inception was -99.15%, roughly equal to the maximum AVXL drawdown of -97.06%. Use the drawdown chart below to compare losses from any high point for KOD and AVXL.


Loading charts...

Drawdown Indicators


KODAVXLDifference

Max Drawdown

Largest peak-to-trough decline

-99.15%

-97.06%

-2.09%

Max Drawdown (1Y)

Largest decline over 1 year

-36.24%

-81.66%

+45.42%

Max Drawdown (3Y)

Largest decline over 3 years

-81.31%

-81.72%

+0.41%

Max Drawdown (5Y)

Largest decline over 5 years

-98.91%

-91.48%

-7.43%

Max Drawdown (10Y)

Largest decline over 10 years

-91.48%

Current Drawdown

Current decline from peak

-77.47%

-91.06%

+13.59%

Average Drawdown

Average peak-to-trough decline

-64.01%

-65.15%

+1.14%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.25%

58.81%

-43.56%

Volatility

KOD vs. AVXL - Volatility Comparison

Kodiak Sciences Inc. (KOD) has a higher volatility of 21.11% compared to Anavex Life Sciences Corp. (AVXL) at 19.81%. This indicates that KOD's price experiences larger fluctuations and is considered to be riskier than AVXL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


KODAVXLDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.11%

19.81%

+1.30%

Volatility (6M)

Calculated over the trailing 6-month period

78.25%

61.46%

+16.79%

Volatility (1Y)

Calculated over the trailing 1-year period

135.98%

88.21%

+47.77%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

109.21%

80.65%

+28.56%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

104.03%

85.34%

+18.69%

Dividends

KOD vs. AVXL - Dividend Comparison

Neither KOD nor AVXL has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

KOD vs. AVXL - Financials Comparison

This section allows you to compare key financial metrics between Kodiak Sciences Inc. and Anavex Life Sciences Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober00
(KOD) Total Revenue
(AVXL) Total Revenue
Values in USD except per share items

Frequently Asked Questions


KOD and AVXL have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

KOD has higher volatility (21.11%) compared to AVXL (19.81%). In terms of maximum drawdown, KOD dropped -99.15% vs AVXL's -97.06%.

KOD currently has the higher Sharpe Ratio (6.84 vs -0.82), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for KOD and AVXL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer